Inventor · disambiguated record
Rashmi Venugopala
Also filed as: VENUGOPALA RASHMI
17 granted patents·0 citations·filing 2023–2024
85Inventor score
Files withUNIV KING FAISAL17
Top patents by PatentIndex Score
17 records- 0177US12145915B1(E)-2-(3-cyano-4-isobutoxyphenyl)-n′-(substituted benzylidene)-4-methylthiazole-5-carbohydrazides as anti-tubercular agentsUNIV KING FAISAL·Filed 2023·Granted Nov 19, 2024·0 cites·13 claims
- 0277US11981674B17-isopropyl 1-ethyl/methyl 3-(substituted benzoyl)-2-substituted indolizine-1,7-dicarboxylates as larvicidal agentsUNIV KING FAISAL·Filed 2023·Granted May 14, 2024·0 cites·17 claims
- 0376US12172973B1(E)-2-(3-Cyano-4-isobutoxyphenyl)-N′-(substituted benzylidene)-4-methylthiazole-5-carbohydrazides as anti-tubercular agentsUNIV KING FAISAL·Filed 2023·Granted Dec 24, 2024·0 cites·2 claims
- 0474US11976076B1Substituted 7,8-dihydropyrimido[4,5-d]pyrimidines as anti-tubercular agentsUNIV KING FAISAL·Filed 2023·Granted May 7, 2024·0 cites·20 claims
- 0573US12145936B17-Imino-5-(1H-indol-3-yl)-1,3-substituted-7,8-dihdropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione as anti-inflammatory agentsUNIV KING FAISAL·Filed 2023·Granted Nov 19, 2024·0 cites·17 claims
- 0673US11958857B15-(1H-indol-3-yl)-1,3-substitutedpyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,8H)-trione as anticancer agentsUNIV KING FAISAL·Filed 2023·Granted Apr 16, 2024·0 cites·13 claims
- 0772US12215082B1(e)-1-(2-(4-substitutedphenyl)-2-oxoethyl)-4-((hydroxyimino)methyl)pyridinium bromides as antitubercular agentsUNIV KING FAISAL·Filed 2024·Granted Feb 4, 2025·0 cites·9 claims
- 0872US11976066B1Substituted 7-amino-3-(substituted benzoyl)indolizine-1-carboxylates as anti-tubercular agentsUNIV KING FAISAL·Filed 2023·Granted May 7, 2024·0 cites·11 claims
- 0972US11926602B14-amino-5-(4-fluoro-3-phenoxyphenyl)-4H-1,2,4-triazole-3-thiol derivatives as antifungal agentsUNIV KING FAISAL·Filed 2023·Granted Mar 12, 2024·0 cites·10 claims
- 1070US11970470B1{5-chloro-2-(2-(3-(substitutedphenyl)-1,2,4-oxadiazol-5-yl)ethyl)phenyl}(phenyl)methanones as larvicidal agentsUNIV KING FAISAL·Filed 2023·Granted Apr 30, 2024·0 cites·18 claims
- 1169US11939294B11-(2-(substituted phenyl)-2-oxoethyl)-3,5-dimethylpyridin-1-ium bromides as antitubercular agentsUNIV KING FAISAL·Filed 2023·Granted Mar 26, 2024·0 cites·8 claims
- 1267US11905279B1Benzylidene derivatives of fenobam as anti-inflammatory agentsUNIV KING FAISAL·Filed 2023·Granted Feb 20, 2024·0 cites·20 claims
- 1366US11981643B1Oxoimidazolidine derivatives as anti-tubercular agentsUNIV KING FAISAL·Filed 2023·Granted May 14, 2024·0 cites·14 claims
- 1466US11970489B14-[(substituted 1H-benzimidazol-2-ylsulfanyl)methyl]-6-substituted-2H-chromen-2-ones as larvicidal agentsUNIV KING FAISAL·Filed 2023·Granted Apr 30, 2024·0 cites·18 claims
- 1565US11998532B1Substituted 1,3,4-oxadiazole derivatives as anti-tubercular agentsUNIV KING FAISAL·Filed 2023·Granted Jun 4, 2024·0 cites·16 claims
- 1665US11981673B17-isopropyl 1,2-dimethyl 3-(substituted benzoyl)indolizine-1,2,7 tricarboxylates as adenosine receptor active compoundsUNIV KING FAISAL·Filed 2023·Granted May 14, 2024·0 cites·17 claims
- 1761US12194029B1Ethyl-1-(substitutedbenzoyl)-5-methylpyrrolo[1,2-a]quinoline-3-carboxylates as anticancer agentsUNIV KING FAISAL·Filed 2023·Granted Jan 14, 2025·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Rashmi Venugopala files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →